1 September 2020 in Asian Journal of Medical Sciences
Background: The impact of high-risk surgery on tissue perfusion can be indirectly assessed by measuring lactate levels during surgery and intensive care unit (ICU) stay. While consistently high values are associated with poor prognosis, transient elevations do not mean poor clinical outcomes. Therefore, intraoperative and early postoperative blood lactate monitoring is essential for cancer patients. Aims and Objective: This study aimed to determine the risk factors of persistently elevated lactate levels in the intraoperative and postoperative period in patients with elective gastric cancer surgery. Materials and Methods: We retrospectively enrolled 293 patients who underwent curative resection for gastric cancer. Lactate values of all patients were examined during surgery and ICU-stay at 3rd, 6th, 12th, and 18th hours. All lactate values above 2 mmol/L were considered elevated. The patients were divided into two groups as those with perioperative persistently increased lactate levels and those without. Results: Of the 293 patients, 60 (20.5%) had higher lactate levels in the perioperative period. According to multivariate logistic regression analysis, the operative time had the highest significance rate (p = 0.020) out of two significant variables, followed by the BMI ≥ 30 kg/m2 (p = 0.048). Besides, patients with perioperative hyperlactatemia had prolonged hospital stays (p = 0.034). Conclusions: Operative time and obesity (BMI ≥ 30 kg/m2) were independent risk factors for persistent lactate elevation in the perioperative period. Also, perioperative hyperlactatemia extended the length of hospital stay.
1 March 2019 in Turkish Journal of Colorectal Disease
4 March 2023 in Clinical Anatomy
26 August 2024 in Acibadem Universitesi Saglik Bilimleri Dergisi
Background/Purpose: In recent studies, Helicobacter pylori (Hp) infection; It was stated that it may be associated with diseases such as obesity, diabetes, chronic obstructive pulmonary disease and kidney failure. In our study, we aimed to examine the relationship between Hp infection and gallstones and gallbladder polyps. Methods: Patients who underwent elective cholecystectomy between January 2017 and December 2021 were retrospectively examined. Patients were divided into those with only polyps in the gallbladder (Group P), those with polyps and stones together (Group SP), and those with only stones (Group S). The control group consisted of patients who underwent gastroscopy due to dyspeptic complaints (Group No). The groups were screened for the presence of Helicobacter pylori. Demographic data, comorbidities, presence of hepatosteatosis and laboratory values were recorded and compared. Results: 244 patients were included in the study. HP was positive in 141 (57.8%) of the patients and negative in 103 (42.2%). There were 58 (23.8%) patients in Group P, 22 (9%) in Group SP, 90 (36.9%) in Group S, and 74 (30.3%) in Group No. There was a significant difference in age between Group P and Group No (P = 0.012). Female gender was significantly higher in Group S (P=0.009). Helicobacter pylori positivity rate was significantly higher in Group P and Group SP (P = 0.012). Conclusion: HP infection may be associated with gallbladder polyps. We recommend that prospective randomized controlled studies be supported by large sample data.
26 July 2022 in Istanbul Yeni Yuzyil Universitesi, Yeni Yuzyil Journal of Medical Sciences
Amaç: Tıpta teknoloji ilerledikçe intraoperatif sinir monitorizasyonu özellikle tiroid ameliyatları için güçlü bir güvenlik aracı haline gelmiştir. Aralıklı veya sürekli intraoperatif sinir monitörizasyonunun (IONM) rekürren laringeal sinir (RLN) felcini azaltmadaki etkinliği, cerrahın deneyim düzeyi ne olursa olsun RLS'nin hasar görmemesini sağlamak için oldukça tartışılan bir konu olmuştur. Bu prospektif çalışmada, tiro- idektomiye bağlı iyatrojenik RLS felcinin önlenmesi için sürekli intraoperatif sinir monitörizasyonunu (C-IONM) aralıklı intraoperatif sinir monitörizasyonu (I-IONM) ile karşılaştırdık. Gereç ve Yöntem: Yaşları 18 ile 75 arasında değişen 109 hasta, sırasıyla -IONM veya C-IONM uygulanan 64 ve 45'er kişilik 2 gruba ayrıldı. Minimal invaziv cerrahi için seçilen hastalarda RLS'lerin tam eksplore edilememesi veya sinirde tümör invazyonu bulunması dışlama kriteri olarak kabul edildi. Bulgular: Grup 2’deki hastaların sinirlerinin %54’ü yüksek risk al- tında olup, bu oran Grup 1’e göre anlamlı derecede yüksek bulundu (p=0.022). Grup 1 ve Grup 2’deki hastalarda kalıcı ve geçici vokal kord paralizlerinin oranları sırasıyla 4,5% - 0,6% ve 2,8% - 0% olarak saptandı. İstatiksel olarak bu oran anlamlı bulunmadı (p>0,05). Yapılan multivaryant analizde ekstra laryngeal sinir dallanmasının varlığının vokal kord paralizi için bağımsız bir risk faktörü olduğu görüldü (p=0.21). Tartışma ve Sonuç: C-IONM, cerrahın önlenebilir RLS hasarını önce- den tespit edip durdurmasını sağladığı için üstün bir tekniktir. RLS felci vakalarının sayısını en aza indirmek ve bilateral RLS paralizisini önlemek için tiroid ameliyatlarında İONM'nin standart bir yaklaşım olarak kullanılması gerektiğine inanıyoruz.
17 July 2026 in Biomolecules and Biomedicine
Total neoadjuvant therapy (TNT) has become an important treatment strategy for locally advanced rectal cancer (LARC), increasing the need for pretreatment biomarkers that may predict major tumor response and support organ-preserving approaches. This study aimed to evaluate whether pretreatment stromal CD4⁺ and CD8⁺ T-cell densities, together with stromal tumor-infiltrating lymphocytes (TILs), are associated with response to TNT in patients with LARC. In this retrospective study, 45 patients with LARC who completed TNT were analyzed; pretreatment colonoscopic biopsy specimens were available for all patients, and paired post-treatment resection specimens were available for 40 surgically treated patients. CD4⁺ and CD8⁺ T-cell densities were assessed immunohistochemically in stromal hotspot areas and expressed as cells/mm², while stromal TILs were evaluated on hematoxylin–eosin sections. A favorable response was defined as tumor regression grade (TRG) 0–1 in surgically treated patients or clinical complete response in patients managed with a watch-and-wait strategy. Median pretreatment CD4⁺ T-cell density, CD8⁺ T-cell density, and stromal TIL percentage were 320 cells/mm², 64 cells/mm², and 30%, respectively. Receiver operating characteristic (ROC) analysis identified a pretreatment stromal CD4⁺ T-cell density cutoff of 410 cells/mm² for favorable response, with an area under the curve (AUC) of 0.68 (p=0.041). CD4⁺ T-cell density >410 cells/mm² was significantly associated with favorable response and remained independently associated with response in multivariable logistic regression analysis (odds ratio [OR]=5.05, 95% confidence interval [CI]: 1.21–20.83, p=0.026). In contrast, pretreatment CD8⁺ T-cell density and stromal TIL percentage were not significantly associated with response. In paired specimens, CD8⁺ T-cell density increased significantly after treatment (p<0.001), whereas CD4⁺ T-cell density and stromal TIL percentage did not change significantly. Lymphovascular invasion (LVI) and perineural invasion (PNI) were associated with non-favorable response. High pretreatment stromal CD4⁺ T-cell density may represent a candidate biomarker of favorable response to TNT in LARC, while the post-treatment increase in CD8⁺ T-cell density suggests a potential immunomodulatory effect of TNT; however, prospective validation in larger cohorts is required.